About Jeremy Friedler

This author has not yet filled in any details.
So far Jeremy Friedler has created 3 blog entries.

Global Trade Compliance: Why Emerging Biopharmaceutical Company Operations Executives Need to Take Notice

By |2021-09-30T13:18:28-04:0009/27/2021|

Today’s biopharmaceutical supply chains often stretch around the world. Key starting materials (KSM) and API originate more frequently from Asia. Manufacturing is commonly conducted in Europe and North America. And commercial distribution is spread across the globe. This globalization has resulted in increased logistics and global trade compliance (GTC) complexity along with ever-changing import/export [...]

Building Supply Chain Resilience: The Biden Administration’s 100-Day Supply Chain Review Findings on Pharmaceuticals and APIs

By |2022-05-10T10:55:54-04:0006/24/2021|

Building Supply Chain Resilience The Biden Administration’s 100-Day Supply Chain Review Findings on Pharmaceuticals and APIs On February 24, 2021, President Biden signed an Executive Order on America’s Supply Chains (EO) as a step toward building more secure, robust and resilient supply chains. The EO initiated a 100-Day Supply Chain Review, which detailed an assessment of the strengths and [...]

The CARES Act & Your Supply Chain: What You Need to Know

By |2021-06-24T11:34:46-04:0006/24/2021|

Jeremy Friedler, senior consultant, and Rashi Gupta, consultant, focus on biotechnology and pharmaceutical operations at Converge Consulting. The COVID-19 pandemic and resulting economic crisis exposed the vulnerabilities of both domestic and global supply chains across multiple industries. Given the complexity and far-reaching global nature of their supply chains, pharmaceutical and biotechnology companies were [...]

Go to Top